AZIYO BIOLOGICS INC's ticker is AZYO and the CUSIP is 05479K106. A total of 18 filers reported holding AZIYO BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102 | -96.6% | 24 | -93.1% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | – | 350 | +2816.7% | 0.00% | – |
| Q1 2022 | $0 | – | 12 | -81.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 63 | -90.2% | 0.00% | – |
| Q3 2021 | $4,000 | -60.0% | 641 | -40.4% | 0.00% | – |
| Q2 2021 | $10,000 | -83.3% | 1,076 | -75.2% | 0.00% | – |
| Q1 2021 | $60,000 | +500.0% | 4,339 | +486.4% | 0.00% | – |
| Q4 2020 | $10,000 | – | 740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 1,655,184 | $2,499 | 1.96% |
| PERKINS CAPITAL MANAGEMENT INC | 275,329 | $416 | 0.39% |
| Prosight Management, LP | 196,443 | $296,629 | 0.14% |
| Indie Asset Partners, LLC | 26,500 | $40,015 | 0.05% |
| Knollwood Investment Advisory, LLC | 58,962 | $89,033 | 0.02% |
| Alyeska Investment Group, L.P. | 214,343 | $323,658 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,134 | $8 | 0.00% |
| US BANCORP \DE\ | 625 | $944 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $85 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |